Clinical effects of plasmapheresis in acute Guillain-Barré syndrome

  • Piccolo G. 
  • Cosi V. 
  • Lombardi M. 
  • Poloni M. 
  • Ceroni M. 
  • Fornasari P. M. 
Original Articles


5 consecutive cases of acute GBS were treated by plasmapheresis (PP). Clinical features and results of therapy have been compared with those of 10 consecutive acute GBS cases untreated by PP. PP treatment, applied early during the phase of deterioration, seemed to stop deficit progression, thus eliminating the stationary stage and triggering recovery immediately. Complete recovery seemed to occur comparatively faster than in the untreated group.


Acute GBS plasmapheresis 


Abbiamo trattato con plasmaferesi 5 casi consecutivi di Sindrome di Guillain-Barré acuta. Le caratteristiche cliniche ed i risultati del trattamento sono stati confrontati con quelli relativi a 10 casi consecutivi precedentemente osservati e non trattati con plasmaferesi. Il trattamento con plasmaferesi, applicato precocemente, ancora in fase di deterioramento, sembra arrestare la progressione sintomatologica, eliminando la fase di stazionarietà e dando inizio ad un immediato recupero; il recupero completo appare occorrere più precocemente nei pazienti trattati.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. [1]
    Asbury K.A.:Diagnostic considerations in Guillain-Barré Syndrome. Ann. Neurol., 9, (Suppl.): 1–5, 1981.PubMedGoogle Scholar
  2. [2]
    Brettle R.P., Gross M., Legg N.J., Lockwood M., Pallis C.:Treatment of acute polyneuropathy by plasma exchange. Lancet 2:1100, 1978.PubMedGoogle Scholar
  3. [3]
    Cook S.P., Dowling P.C., Murray M.R., Whitaker J.N.:Circulating demyelinating factors in acute idiopathic polyneuropathy. Arch. Neurol 24: 136–144, 1971.PubMedGoogle Scholar
  4. [4]
    Cooperative French Group (Raphael J.C. et al):Cooperative randomised trial of plasma exchange in Guillain-Barré Syndrome. Preliminary results. Annales de Médecine Interne 135, 8, 1984 (Abs).Google Scholar
  5. [5]
    English Cooperative Group (Grenwood R.J. et al):Controlled trial of plasma exchange in acute inflammatory polyradiculo-neuropathy. Annales de Médecine Interne 135, 9, 1984 (abs).Google Scholar
  6. [6]
    Feasby T.E., Hahn A.F., Gilbert J.J.:Passive transfer of demyelinating activity in Guillain-Barré polyneuropathy. Neurology (Minneap.) 30:363, 1980.Google Scholar
  7. [7]
    Goust J.M., Chenais F., Canes J.E., Fudenberg H.H., Hogan E.L.:Abnormal T cell subpopulations and circulating immune complexes in the Guillain-Barré Syndrome and in multiple sclerosis. Neurology (Minneap.) 28:421–425, 1978.Google Scholar
  8. [8]
    Gross M.L.P., Thomas P.K.:The treatment of chronic progressive and chronic relapsing polyneuropathy by plasma exchange. J. Neurol. Sci. 52: 69–78, 1981.CrossRefPubMedGoogle Scholar
  9. [9]
    Gross M.L.P., Legg, N.J., Lockwood M.C., Pallis C.:The treatment of inflammatory polyneuropathy by plasma exchange. J. Neurol Neurosurg Psychiat. 45:675–679, 1982.PubMedGoogle Scholar
  10. [10]
    Heininger K., Toyka K.V., Libert U., Kolb-Bachofen V., Haneveld F., Schwendemann G.: Besinger U.A., Cleveland H.G., Ross H.G.:Induction of an experimental neuropathy in the monkey by passive transfer of immunoglobuline (Ig) from human chronic inflammatory polyneuropathy. Abstr. Fifth Internat Congress on Neuromuscular Diseases, Marseille, 1982.Google Scholar
  11. [11]
    John Hopkins University School of Medicine:The effects of Plasmapheresis on the acute Guillain-Barré Syndrome. Annales de Médecine Interne 135, 8, 1984.Google Scholar
  12. [12]
    Kennard C., Newland A.C., Ridley A.:Treatment of the Guillain-Barré Syndrome by plasma exchange. J Neurol Neurosurg Psychiat, 45/847–850, 1982.PubMedGoogle Scholar
  13. [13]
    Yonezawa T., Ischihara Y., Matsuyama H.:Studies on experimental allergic peripheral neuritis. II.Demyelinating patterns studied in vitro. J Neuropathol Exp Neurol 27:453, 1968.Google Scholar
  14. [14]
    Luijten J.A.F.M., Bart de la Faille-Kuyper E.H.:The occurrence of IgM and complement factors along myelin sheaths of peripheral nerves. An immunohistochemical study of the Guillain-Barré Syndrome. J Neurol Sci 15:219–224, 1972.CrossRefPubMedGoogle Scholar
  15. [15]
    Mayo Clinic Mayo Foundation (Dyck P.J. et al):Plasma exchange in chronic inflammatory demyelinating polyradiculoneuropathy, a controlled, double-blind trial. Annales de Médecine interne 135, 9, 1984, (abs).Google Scholar
  16. [16]
    Melnick S.C.:Thirty-eight cases of the Guillain-Barré Syndrome — an immunological study. Br Med J 2:936–938, 1963.Google Scholar
  17. [17]
    Ostermann P., Fagius J., Säfwenbërg J., Danersund A., Wallin B., Nordejö D.:Treatment of the Guillain-Barré Syndrome by plasmapheresis. Arch Neurol 39:148–154, 1982.Google Scholar
  18. [18]
    Rumpl E., Mayr U., Gerstendrand F., Hackl J.M., Rosmanith P., Aichner F.:Treatment of Guillain-Barré Syndrome by plasma exchange. J Neurol 225:207–217, 1981.CrossRefPubMedGoogle Scholar
  19. [19]
    Saida T., Saida K., Silverberg D.H., Brown M.J.:Transfer of demyelination by intraneural injection of experimental allergic neuritis-serum. Nature 272:639–641, 1978.CrossRefPubMedGoogle Scholar
  20. [20]
    Schott B.H., Camer H., Chagot G., Brady B., Barbaret C.:Immunofluorescence and immune labelling with H-R peroxidase in the peripheral neuropathies. Excerpta Medica 477:182, 1977.Google Scholar
  21. [21]
    The Guillain-Barré Syndrome Study Group:Plasmapheresis and Acute Guillain-Barré Syndrome. Neurology 35:1096–1104, 1985.Google Scholar
  22. [22]
    Toronto General Hospital (Schumak K.H. et al):Toronto General Hospital controlled trial data on plasma exchange therapy in Guillain-Barré Syndrome. Annales de Médecine Interne 135, 9, 1984 (abs).Google Scholar
  23. [23]
    University of Sydney Pollard J.D., McLeod J.G.:Plasma exchange in chronic inflammatory demyelinating polyneuropathy. Annales de Médicine Interne 135, 9, 1984 (abs).Google Scholar
  24. [24]
    Valbonesi M., Garelli S., Mosconi L., Zerbi D., Celano I.:Plasma exchange as a therapy for Guillain-Barré Syndrome with immune complexes. Vox Sanguinis, 41:74–78, 1981.PubMedGoogle Scholar
  25. [25]
    Zerbi D., Celano I., Foriani G., Garelli S., Valbonesi M.:Plasmapheresis in the treatment of four cases of Guillain-Barré Syndrome (acute form). Ital J Neurol Sci 4:331–336, 1981.Google Scholar

Copyright information

© Masson Italia Periodici S.r.l. 1986

Authors and Affiliations

  • Piccolo G. 
    • 1
  • Cosi V. 
    • 1
  • Lombardi M. 
    • 1
  • Poloni M. 
    • 2
  • Ceroni M. 
    • 1
  • Fornasari P. M. 
    • 3
  1. 1.Istituto Scientifico C. Mondino, Clinica NeurologicaUniversità di PaviaPavia
  2. 2.Clinica Neurologica IUniversità di MilanoMilanoItaly
  3. 3.Centro Emotrasfusionale AVISPavia

Personalised recommendations